136
A. B. Hughes and B. E. Sleebs
washed successively with 10% citric acid solution (20 mL), sat-
urated sodium bicarbonate solution (20 mL), and brine (20 mL).
The ethereal layer was dried (MgSO4) and concentrated under
reduced pressure. The resulting oil was purified using column
chromatography, with 10% ethyl acetate/hexane as eluent, to
yield the ester 17 as a clear colourless oil (75% yield). [α]D20
−20.0(c1.0, CH2Cl2). δH (300 MHz, CDCl3)7.32(5H, s), 5.88–
5.84 (1H, m), 5.20–5.05 (4H, 2m), 4.46 (2H, s), 4.08–4.02 (1H,
m), 2.80 (3H, s), 2.60 (2H, s), 1.78–1.70 (1H, m), 0.92–0.86
(6H, m). δC (75 MHz, CDCl3) (rotamers) 171.2, 156.5, 137.0,
132.2, 128.3, 127.7, 118.2, 67.1, 66.8, 65.2, 60.6, 59.9, 36.4,
35.9, 30.9, 30.6, 19.9, 19.5. νmax (NaCl)/cm−1 3030, 2965 (CH),
1737, 1699 (CO), 1470, 1404, 1335, 1305, 1176, 1142, 989, 768,
698. (Found: C 67.6, H 7.8, N 4.4. Calc. for C18H25NO4: C 67.7,
H 7.9, N 4.4%.)
1336, 1263, 1151, 767, 698. (Found: C 63.5, H 8.0, N 7.4. Calc.
for C20H30N2O5: C 63.5, H 8.0, N 7.4%.)
Ethyl-2-[(3S)-N-benzyloxycarbonyl-3-
aminomethylbutanamido]-2-methylaminoethanoate 23
To the diazoketone 1[20] (0.9 mmol) and sarcosine ethyl
ester hydrochloride 22 (3.6 mmol) dissolved in dry 1,4-dioxane
(5 mL) was added triethylamine (3.6 mmol) and silver triflu-
oroacetate (0.09 mmol). The solution was then sonicated for
45 min.The mixture was concentrated under vacuum, the residue
was diluted with ether (20 mL), and the ethereal layer was
washed successively with 10% citric acid solution (20 mL), sat-
urated sodium bicarbonate solution (20 mL), and brine (20 mL).
The ethereal layer was dried (MgSO4) and concentrated under
reduced pressure. The resulting oil was purified using column
chromatography, with 40% ethyl acetate/hexane as eluent, to
afford the dipeptide 23 as a clear colourless oil (38% yield). [α]D20
+6.50 (c 1.1, CH2Cl2). δH (300 MHz, CDCl3) 7.28 (5H, s), 5.08
(2H, s), 4.38–4.46 (1H, m), 4.12 (2H, q, J 7.1), 4.03–3.92 (2H,
m), 3.06–2.83 (6H, 2m), 2.59–2.20 (2H, m), 1.23–1.19 (6H, 2m).
δC (75 MHz, CDCl3) (323 K) 171.0, 169.0, 155.7, 136.9, 128.3,
127.7, 66.8, 60.8, 50.0, 49.4, 37.9, 36.4, 30.4, 17.7, 14.0. νmax
(NaCl)/cm−1 3320, 3032, 2938 (CH), 1746, 1697, 1651 (CO),
1456, 1402, 1330, 1202, 1150, 1024, 699. (Found: C 61.8, H 7.4,
N 7.9. Calc. for C18H26N2O5: C 61.7, H 7.5, N 8.0%.)
β-Peptides
(2S)-Methyl-2-[(3S)-N-benzyloxycarbonyl-3-
aminomethylbutanamido]-3-methylbutanoate 19
To the diazoketone 1[20] (0.9 mmol) and l-valine methyl ester
hydrochloride (3.6 mmol) dissolved in dry 1,4-dioxane (5 mL)
were added triethylamine (3.6 mmol) and silver trifluoroacetate
(0.09 mmol). The solution was then sonicated for 45 min. The
mixture was concentrated under vacuum, the residue was diluted
with ether (20 mL), and the ethereal layer was washed succes-
sively with 10% citric acid solution (20 mL), saturated sodium
bicarbonate solution (20 mL), and brine (20 mL). The ethe-
real layer was dried (MgSO4) and concentrated under reduced
pressure. The resulting oil was purified using column chro-
matography, with 40% ethyl acetate/hexane as eluent, to give the
dipeptide 19 as a clear colourless oil (66% yield). [α]2D0 +9.83
(c 1.7, CH2Cl2). δH (300 MHz, CDCl3) 7.20 (5H, s), 6.82–6.70
(1H, m), 4.99 (2H, s), 4.43–3.37 (2H, 2m), 3.55 (3H, s), 2.70
(3H, s), 2.49–2.31 (2H, m), 2.03–1.96 (1H, m), 1.06 (3H, s),
0.79–0.74 (6H, m). δC (75 MHz, CDCl3) (323 K) 171.9, 170.0,
155.6, 136.6, 128.0, 127.4, 127.3, 66.6, 57.0, 51.4, 49.7, 40.8,
30.6, 29.2, 18.4, 17.5. νmax (NaCl)/cm−1 3323 (NH), 3030,
2965 (CH), 1744, 1695, 1651 (CO), 1538, 1454, 1334, 1207,
1151, 1017, 769, 698. (Found: C 62.7, H 7.6, N 7.6. Calc. for
C19H28N2O5: C 62.6, H 7.7, N 7.7%.)
(2S)-tert-Butyl-2-[(3S)-N-benzyloxycarbonyl-
3-aminomethy-butanamido]-2-methylamino-
3-butanoate 25
Using the ketene intermediate. To the diazoketone 1[20]
(0.9 mmol) and N-methyl-α-valine tert-butyl ester tosylate
salt 24 (3.6 mmol) dissolved in dry 1,4-dioxane (5 mL) were
added triethylamine (3.8 mmol) and silver trifluoroacetate
(0.09 mmol). The solution was then sonicated for 45 min. The
mixture was concentrated under vacuum, the residue was diluted
with ether (20 mL), and the ethereal layer was washed succes-
sively with 10% citric acid solution (20 mL), saturated sodium
bicarbonate solution (20 mL), and brine (20 mL). The ethe-
real layer was dried (MgSO4) and concentrated under reduced
pressure. The resulting oil was purified using column chro-
matography, with 20% ethyl acetate/hexane as eluent, to fur-
nish the dipeptide 25 as a clear colourless oil (27% yield).
[α]2D0 −76.86 (c 1.1, CH2Cl2). δH (300 MHz, CDCl3) 7.27
(5H, s), 5.07 (2H, s), 4.77–4.44 (2H, 2m), 2.96–2.81 (6H,
2m), 2.60–2.48 (2H, m), 2.11–2.00 (1H, m), 1.41–1.39 (9H,
m), 1.21 (3H, s), 0.96 (3H, d, J 6.5), 0.78 (3H, d, J 6.7).
δC (75 MHz, CDCl3) (rotamers) (323 K) 170.9, 170.1, 169.0,
155.7, 136.9, 128.3, 127.7, 81.8, 81.1, 66.8, 62.3, 50.0, 38.4,
37.8, 31.4, 30.5, 27.9, 27.3, 19.7, 19.4, 18.9, 18.5, 17.7.
νmax (NaCl)/cm−1 2968, 2935 (CH), 1729, 1699, 1652 (CO),
1473, 1456, 1419, 1401, 1153, 698. (Found: C 65.6, H 8.6,
N 6.7. Calc. for C23H36N2O5: C 65.7, H 8.6, N 6.7%.)
Using PyBrOP as coupling reagent. To a stirred solution
of the N-methylated-β-amino acid 28[20] (0.45 mmol) and the
α-N-methylated residue 24 (0.54 mmol) in dichloromethane
(1 mL) were added PyBrOP (0.54 mmol) and diisopropylethyl-
amine (1.8 mmol) at 0◦C. The mixture was allowed to warm to
room temperature and it was stirred for 20 h. The solution was
diluted with dichloromethane (10 mL).The solution was washed
successively with 10% citric acid solution (10 mL), saturated
sodium bicarbonate solution (10 mL), and water (10 mL). The
organic layer was dried (MgSO4) and concentrated under vac-
uum. The residue was applied to a silica column, with 20% ethyl
(2S)-Methyl-2-[(3S)-N-benzyloxycarbonyl-3-
aminomethylpentanamido]-3-methylbutanoate 21
To the diazoketone 20[20] (0.9 mmol) and valine methyl ester
hydrochloride (3.6 mmol) dissolved in dry 1,4-dioxane (5 mL)
were added triethylamine (3.6 mmol) and silver trifluoroacetate
(0.09 mmol). The solution was then sonicated for 45 min. The
mixture was concentrated under vacuum, the residue was diluted
with ether (20 mL), and the ethereal layer was washed succes-
sively with 10% citric acid solution (20 mL), saturated sodium
bicarbonate solution (20 mL), and brine (20 mL). The ethe-
real layer was dried (MgSO4) and concentrated under reduced
pressure. The resulting oil was purified using column chro-
matography, with 40% ethyl acetate/hexane as eluent, to give
the dipeptide 21 as a clear colourless oil (55% yield). [α]D20
+0.68(c1.5, CH2Cl2). δH (300 MHz, CDCl3)7.18(5H, s), 6.81–
6.58 (1H, m), 5.11–4.89 (2H, m), 4.36–4.19 (2H, m), 3.53 (3H,
s), 2.66 (3H, s), 2.51–2.31 (2H, m), 1.99–1.92 (1H, m), 1.48–
1.36 (2H, m), 0.77–0.66 (9H, 2m). δC (75 MHz, CDCl3) (323 K)
171.8, 170.0, 156.1, 136.5, 128.0, 127.4, 127.2, 66.6, 57.0, 55.8,
51.4, 39.5, 30.5, 29.7, 25.0, 18.4, 17.5, 10.2. νmax (NaCl)/cm−1
3320 (NH), 2964, 2935 (CH), 1743, 1698 (CO), 1536, 1437,